Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 30. May 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9413  Previews Next
   
   Articles 1 - 20 / 188244  
   
MSTM-Net: a two-stage prostate cancer segmentation network based on swin-transformer-mamba architecture.
BMC Med Imaging
Chen J, Liu X, Wang S, Ji W.
PMID: 42215932 [PubMed - as supplied by publisher]


Trends and etiological profile of kidney cancer in China from 1990 to 2023: an analysis of modifiable risk factors and prevention implications using GBD 2023 estimates.
Int J Clin Oncol
Ye Z, Wu H, Zhang C, Wang R, Deng X, Hu E, Wang Z, Gao B.
PMID: 42215789 [PubMed - as supplied by publisher]


Development and validation of a noninvasive machine learning model using urinary extracellular vesicle physical parameters for prostate cancer diagnosis.
Sci Rep
Jiang K, Pan D, Yu J, Cai W, Zhang B, Wang Z, Lu Y, Wang D, Li X, Zheng D, Wang M, Wang F, Chen J.
PMID: 42215604 [PubMed - as supplied by publisher]


Unmet Treatment Need and Challenges Associated with Comparative Evidence Generation in BCG-unresponsive Non-muscle-invasive Bladder Cancer: An Expert Consensus.
Eur Urol Oncol
Gontero P, Perry R, Bridge D, Delattre DD, Vosgerau S, Wyn R, Stone M, Babjuk M.
PMID: 42215335 [PubMed - as supplied by publisher]


AI-MIRACLE: Artificial Intelligence and MultIpaRAmetric MRI Predict CLinical OutcomEs to Neoadjuvant Immunotherapy in Patients with Muscle-invasive Bladder Cancer Undergoing Radical Cystectomy.
Eur Urol Oncol
Necchi A, Brembilla G, Whiting K, Arita Y, Akin O, Apte A, Awais M, Lema-Dopico A, Paudyal R, Cosenza M, Maiorano BA, Tateo V, Cigliola A, Mercinelli C, De Cobelli F, Capanu M, Shukla-Dave A, Schwartz LH.
PMID: 42215334 [PubMed - as supplied by publisher]


Dyadic Coping and Its Influencing Factors in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy and Their Spouses: A Latent Class Analysis.
J Clin Nurs
Chen H, Li Y, He H, Lin H, Song X, Li K.
PMID: 42215288 [PubMed - as supplied by publisher]


Emerging role of urinary biomarkers in bladder cancer diagnosis and prognosis.
Urol Oncol
Paleru G, Singathala GS, Kural S, Kumar L.
PMID: 42214859 [PubMed - as supplied by publisher]


Clinical Manifestations, Tumor Associations, and Long-Term Outcomes of Anti-KLHL11 Encephalitis.
Neurol Neuroimmunol Neuroinflamm
Jin M, Brand T, Erdag Turgeon E, Havelaar AC, Van Steenhoven RW, Nagtzaam MMP, Franken SC, Abu Hassan SHB, Bastiaansen AEM, Brenner J, Sillevis Smitt PAE, de Graaff E, Veenbergen S, de Vries JM, Kerstens J, Titulaer MJ.
PMID: 42214057 [PubMed - indexed for MEDLINE]


Prostate Cancer Treatment Patterns and Inequities Among Racial Groups in Brazil's Public Health System: Insights From a 16-Year Real-World Study.
JCO Glob Oncol
Herchenhorn D, Abboud H, Freire V, Tarouquella J, Monteiro FSM, Fay AP, Freitas JLR, Mckay RR, Rose B, Carvalhal GF, Morbeck I, Maluf FC, Souza VC, Valverde D, Firmino EF, Sasse AD, Bastos D, James N.
PMID: 42214044 [PubMed - indexed for MEDLINE]


Genitourinary Oncology Highlights from the European Society for Medical Oncology Annual Meeting 2025: Advances in Renal Cell Carcinoma and Muscle-invasive Bladder Cancer.
Oncol Res Treat
Zhang XW, Schlack K, Hartmann A, Steiner T, Siska PJ.
PMID: 42213621 [PubMed - as supplied by publisher]


Letter to the Editor: Diagnostic performance of the clear cell likelihood score integrated with cystic degeneration or necrosis on MR imaging for identifying clear cell renal cell carcinoma in cT1 solid renal masses.
Insights Imaging
Hekimsoy .
PMID: 42213342 [PubMed]


Reply to the Letter to the Editor: Diagnostic performance of the clear cell likelihood score integrated with cystic degeneration or necrosis on MR imaging for identifying clear cell renal cell carcinoma in cT1 solid renal masses.
Insights Imaging
Ning X, Wang H.
PMID: 42213314 [PubMed]


Comparative efficacy and safety of open, laparoscopic, and robot-assisted radical cystectomy: a systematic review and network meta-analysis.
J Robot Surg
Zhao L, Chen HM, Li YT, Zhang T, Yang JW, Wang L, Li XR, Shao LC, Chen SY.
PMID: 42213216 [PubMed - indexed for MEDLINE]


Long-Term Clinical Outcomes of Advanced Germ Cell Tumors: Experience From 105 Patients Over 20 Years.
Int J Urol
Yamashita R, Sakura Y, Sugino T, Notsu A, Matsuo T, Hayashi Y, Ito K, Shinsaka H, Nakamura M, Matsuzaki M, Niwakawa M.
PMID: 42212783 [PubMed - indexed for MEDLINE]


Addition of Intravesical Recombinant BCG to Perioperative Chemo-Immunotherapy in Muscle-Invasive Bladder Cancer: Primary Analysis of the Single-Arm Phase 2 Trial SAKK 06/19.
J Clin Oncol
Cathomas R, Petrausch U, Hayoz S, Spahn M, Bubendorf L, Schäuble K, Strebel RT, Niederberger P, Stenner F, Hirschi A, Vogl U, Lorch A, Tsantoulis P, Aeppli S, Erdmann A, Maranta AF, Fankhauser C, Hötker AM, Pausch AM, Herzig P, Le Gall V, Zippelius A, Chiquet S, Rothschild SI, Rentsch CA.
PMID: 42212670 [PubMed - as supplied by publisher]


Sex-Specific Adverse Events and Cardiovascular Toxicity of Cabozantinib in Renal Cell Carcinoma: A Nine-Year Pharmacovigilance Study.
Cancer Invest
Bao E, Li Y, Yang Y, Wang B, Yang Q, Li S.
PMID: 42212588 [PubMed - as supplied by publisher]


Prognostic significance of pretreatment hydronephrosis in radiotherapy-based bladder-preserving strategies for muscle-invasive bladder cancer: a systematic review and meta-analysis.
Arch Ital Urol Androl
Nasution RFG, Warli SM, Prapiska FF.
PMID: 42212459 [PubMed - as supplied by publisher]


Updates and controversies in contemporary grading of clear cell renal cell carcinoma and papillary renal cell carcinoma.
Histopathology
Paner GP, Amin MB, Kwon JW, Cheng L, Moch H.
PMID: 42212433 [PubMed - as supplied by publisher]


Delayed diagnostic imaging but stable treatment initiation for kidney cancer during the COVID-19 pandemic: a Hungarian cohort study.
Pathol Oncol Res
Rumi L, Szántó Á, Bányai D, Szabó É, Bellyei S, Hubai D, Takáts B, Bodnár T, Girán J, Kiss I, Boronkai Á, Pozsgai É.
PMID: 42211878 [PubMed - indexed for MEDLINE]


Correction: Study on the mechanism of 18β-glycyrrhetinic acid inhibiting the proliferation of renal cancer cells by inducing autophagy through the miR-27a-5p/LC3 axis.
Front Oncol
Jia S, Zhang L, Li Y, Xu D, Yang Y, Zhou Z, Liu W, Zhao J, Yuan L, Nan Y.
PMID: 42211520 [PubMed]


   
   Articles 1 - 20 / 188244    Page 1 of 9413  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1